Clinical Study of Nasopharyngeal Carcinoma Treated by Helical Tomotherapy in China: 5-Year Outcomes

Abstract

Helical tomotherapy for NPC patients achieved excellent 3-year locoregional control, distant metastasis-free survival, and overall survival, with relatively minor acute and late toxicities. Age and T stage were the main prognosis factors.

References

Page 1

	Year	Citations
Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. Muhyi Al‐Sarraf, Michael LeBlanc, Padmini Giri, Journal of Clinical Oncology	1998	2.2K
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival James A. Bonner, Paul M. Harari, J. Giralt, The Lancet Oncology Advanced HeadNeck CancerRadiation TherapyMedicineRandomised Trial	2009	2K
Tomotherapy: A new concept for the delivery of dynamic conformal radiotherapy T Mackie, Timothy Holmes, Stuart Swerdloff, Medical Physics Computed TomographySlice TherapyCt ScannerBiomedical EngineeringDynamic Conformal Radiotherapy	1993	1.1K
Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience Nancy Lee, Ping Xia, Jeanne M. Quivey, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyRadiation TherapyMedicineNasopharyngeal CancerIntensity-modulated Radiotherapy	2002	986
Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225 Nancy Lee, Jonathan Harris, Adam S. Garden, Journal of Clinical Oncology	2009	693
A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma Gang Peng, Tao Wang, Kunyu Yang, Radiotherapy and Oncology Radiation TherapyConventional Two-dimensional RadiotherapyMedicineNasopharyngeal CancerIntensity-modulated Radiotherapy	2012	634
How Does Intensity-Modulated Radiotherapy Versus Conventional Two-Dimensional Radiotherapy Influence the Treatment Results in Nasopharyngeal Carcinoma Patients? Shu-zhen Lai, Wen‐Fei Li, Lei Chen, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyRadiation TherapyMedicineRadionuclide TherapyTreatment Results	2010	611
Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience Michael Kam, Peter M.L. Teo, Ricky Ming-chun Chau, International Journal of Radiation OncologyBiologyPhysics Radiation TherapyMedicineNasopharyngeal CancerHong Kong ExperienceIntensity-modulated Radiotherapy	2004	506
Randomized Trial of Radiotherapy Plus Concurrent-Adjuvant Chemotherapy vs Radiotherapy Alone for Regionally Advanced Nasopharyngeal Carcinoma A. W. M. Lee, Shui‐Yi Tung, Dtt Chua, JNCI Journal of the National Cancer Institute	2010	320
Use of the Humanized Anti-Epidermal Growth Factor Receptor Monoclonal Antibody h-R3 in Combination With Radiotherapy in the Treatment of Locally Advanced Head and Neck Cancer Patients Tania Crombet, Marta Osorio, Teresa Cruz, Journal of Clinical Oncology	2004	298

Page 1